Mesenchymal Cellule staminali may be a viable treatment option for Post Treatment Lyme Disease Syndrome (PTLDS). Cellule staminali have been proven to have strong anti-inflammatory properties. Through the use of large cell quantity transplants, the youthful cellule staminali have a regulatory nature on the body


NBScienza

organizzazione di ricerca a contratto